DALLAS, September 23, 2013 /PRNewswire/ --
The "Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 - 2018)", analyzes & studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, & Rest of the World (ROW).
Browse 131 market data tables and 23 figures spread through 327 pages and in-depth TOC on "Biomarkers Market"
Early buyers will receive 10% customization on this report.
This report studies the global Biomarkers Market over the forecast period of 2013 to 2018. A number of factors such as the rising demand for personalized medicine and companion diagnostics have increased the utility of Biomarkers in the healthcare sector. The global Biomarkers Market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.
Omics technology including, proteomics, genomics, transcriptomics, and metabolomics, is the largest segment of the global Biomarkers discovery technology market. Advancement in discovery technologies such as genome sequencing is the prime factor contributing to the growth of this market.
The discovery and development of Biomarkers is costly and is a highly time consuming procedure. Application of Biomarkers in drug discovery & development reduces the overall cost of the entire drug development process; hence, demand for novel Biomarkers is expected to increase in
Copyright©2012 PR Newswire.
All rights reserved